Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00090610. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Phase II Comparative Study to Compare Efficacy & Safety of Taxotere®/Carboplatin Combination Therapy vs Sequential Therapy w/ Taxotere® Then Carboplatin as Second-line Treatment of Patients w/ Relapsed, Platinum-sensitive Ovarian Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the progression-free survival of two treatment regimens for relapsed ovarian cancer.
Study identification
- NCT ID
- NCT00090610
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2003 (Type not available)
- Primary completion
- Mar 2009 (Actual)
- Completion
- Oct 2009 (Actual)
- Last update posted
- Feb 25, 2015
2003 – 2009
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Florida Gynecologic Oncology | Fort Myers | Florida | 33901 | — |
| Jupiter Medical Center-Gynecology Oncology and Gynecology | Jupiter | Florida | 33458 | — |
| Florida Hospital/Gyn/Onc Department | Orlando | Florida | 32804 | — |
| Hematology-Onc. Assoc. of The Quad Cities | Bettendorf | Iowa | 52722 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Franklin Square Hospital Center/MedStar Health-Section of Hematology/Oncology | Baltimore | Maryland | 21237-3998 | — |
| Cancer Center at Hackensack | Hackensack | New Jersey | 07601 | — |
| Columbia University College of Physicians and Surg | New York | New York | 10032 | — |
| Hope: A Woman's Cancer Center | Asheville | North Carolina | 28816 | — |
| University of North Carolina/ Division of Gyn Oncology | Chapel Hill | North Carolina | 27599-7570 | — |
| Carolinas Medical Center/Gyn Oncology Department | Charlotte | North Carolina | 28232 | — |
| Duke University/Division of Gynecologic Oncology | Durham | North Carolina | 27710-0001 | — |
| Forsyth Regional Cancer Center | Winston-Salem | North Carolina | 27103 | — |
| Gynecologic Oncology and Surgery | Oklahoma City | Oklahoma | 73112 | — |
| PA Hematology/Oncology Associates | Philadelphia | Pennsylvania | 19106 | — |
| Western Pennsylvania Hospital | Pittsburgh | Pennsylvania | 15224 | — |
| MUSC-Div of Gyn/Oncology | Charleston | South Carolina | 29425 | — |
| The West Cancer Clinic | Memphis | Tennessee | 38120 | — |
| Southwest Regional Cancer Center | Austin | Texas | 78705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00090610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 25, 2015 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.